organophosphonates has been researched along with Acquired Immune Deficiency Syndrome in 107 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (1.87) | 18.7374 |
1990's | 21 (19.63) | 18.2507 |
2000's | 54 (50.47) | 29.6817 |
2010's | 30 (28.04) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allen, ME; Brown, J; Karakas, SE; Pollard, RB | 1 |
Hawkes, N | 1 |
Oyler, NA; Youan, BC; Zhang, C; Zhang, T | 1 |
Arnedo, M; Domingo, P; Egaña-Gorroño, L; Escribà, T; Fontdevila, J; Gatell, JM; Loncà, M; Martínez, E; Negredo, E; Vidal, F | 1 |
Guedj, R | 1 |
Andrews, M; Condoluci, DV; Luber, AD | 1 |
Barkil, ME; Boibieux, A; Cotte, L; Gagnieu, MC; Guitton, J; Livrozet, JM; Miailhes, P; Tod, M | 1 |
Lavae-Mokhtari, M; Mohammad-Khani, S; Schmidt, RE; Stoll, M | 1 |
Mohammadi, D | 1 |
Boissier, MC; Prendki, V; Prie, D; Saidenberg-Kermanac'h, N; Souabni, L | 1 |
Wainberg, MA | 1 |
Arrivé, E; Blanche, S; Dabis, F; Ekouévi, DK; Gray, G; Hirt, D; Kone, M; Kruy, LS; Nerrienet, E; Nyati, M; Pruvost, A; Tréluyer, JM; Urien, S | 1 |
Amani-Bosse, C; Arrivé, E; Avit, D; Blanche, S; Dabis, F; Ek, ML; Ekouévi, DK; Hirt, D; Legote, S; McIntyre, J; Nyati, M; Pruvost, A; Say, L; Tréluyer, JM; Urien, S | 1 |
Hakim, JG; Katsidzira, L | 1 |
Andrade-Villanueva, J; Boven, K; Clotet, B; Cohen, CJ; Crauwels, H; Fourie, J; Johnson, MA; Rimsky, LT; Ruxrungtham, K; Vanveggel, S; Wu, H; Zorrilla, C | 1 |
Boven, K; Cahn, P; Crauwels, H; Grinsztejn, B; Lazzarin, A; Mills, A; Molina, JM; Rimsky, LT; Saag, M; Supparatpinyo, K; Vanveggel, S; Walmsley, S | 1 |
Donnelly, J | 1 |
Blanch, J; Cervantes, M; Domingo, P; Ferrer, E; Knobel, H; Llibre, JM; Mallolas, J; Pedrol, E; Vallecillo, G | 1 |
Bazewicz, M; Caspers, L; Fikri, J; Frippiat, F; Libois, A; Martin, CH; Meunier, A; Willermain, F | 1 |
Couto, ER; de Rezende, SM; Moretti, ML; Morsch Passos, AI | 1 |
Venkataramanan, M | 1 |
Buckheit, KW; Buckheit, RW; Goldman, L; Gwozdz, G; Ham, AS; Kiser, PF; Lakougna, H; Nagaraja, U; Shi, L; Ugaonkar, SR | 1 |
Arasteh, K; Boven, K; Crauwels, H; De Wet, J; Gathe, J; Gold, J; Hodder, S; Kumar, P; Mohapi, L; Short, W; Vanveggel, S | 1 |
Islam, FM; Jansson, J; Wilson, DP; Wu, J | 1 |
Chinthapalli, S; Mandalia, S; Martin, T; Nelson, M; Scourfield, A; Waters, L; Zheng, J | 1 |
Aga, E; Badal-Faesen, S; Bartlett, JA; Crump, JA; Hosseinipour, MC; Kallungal, BA; Katzenstein, DA; Klingman, KL; Kumarasamy, N; Norton, MR; Ribaudo, HJ; Stevens, WS; Supparatpinyo, K; Wallis, CL | 1 |
Goicochea, P; Grant, RM; Liu, A; Marcus, JL; McMahan, V; R Amico, K; Vargas, L | 1 |
Bloom, A; Brown, TT; Daar, ES; Fedarko, N; Ha, B; Jahed, NC; Kitch, D; McComsey, GA; Melbourne, K; Sax, PE; Tierney, C | 1 |
Powderly, WG | 1 |
Casado, JL; del Palacio, M; Romero, S | 1 |
Carda-Broch, S; Casas-Breva, I; Esteve-Romero, J; Peris-Vicente, J; Rambla-Alegre, M | 1 |
Aboulafia, D; Berry, JM; Da Costa, M; Darragh, TM; Einstein, MH; Goldstone, SE; Jay, N; Lee, JY; Palefsky, JM; Panther, L; Stier, EA; Wilkin, T | 1 |
Ambrosioni, J; Calmy, A; Daou, S; Merkler, D | 1 |
Kimberlin, DW | 1 |
Gallant, JE | 1 |
Mitchell, SM; Obi, AA; Zambarakji, HJ | 1 |
Cauda, R; Minnella, A; Rabagliati, R; Scoppettuolo, G; Tacconelli, E; Tumbarello, M; Ventura, G | 1 |
Aries, SP; Dalhoff, K; Kramme, E; Schaaf, B; Steinhoff, J | 1 |
Clarke, B | 1 |
Holy, A | 1 |
Check, E | 1 |
Abad, S; Blanche, P; Chauvelot-Moachon, L; Daniel, N; Kélaïdi, C; Nazal, EM; Rollot, F; Saba, M | 1 |
Benhamou, Y; Poynard, T | 1 |
Bassett, R; Currier, JS; DeGruttola, V; Demeter, LM; Eron, JJ; Fischl, MA; Hammer, SM; Mellors, JW; Morse, GD; Santana, JL; Squires, KE | 1 |
Chen, SS; Cheng, A; Lu, B; Margot, N; Miller, MD; Wulfsohn, M; Zhong, L | 1 |
Mauss, S | 1 |
Dressier, RM; James, CW; Steinhaus, MC; Szabo, S | 1 |
Lajusticia, J; Ramos, C | 1 |
Baldanti, F; Gerna, G; Lurain, N | 1 |
Perazella, MA; Rifkin, BS | 1 |
Esser, S; Fätkenheuer, G; Hoffmann, C; Lorenzen, T; Qurishi, N; Rieke, A; Rockstroh, J; Ross, B; Salzberger, B; Schmeisser, N; Schmitz, K; Stenzel, W; Wöhrmann, A; Wyen, C | 1 |
Cheng, AK; Coakley, DF; Margot, NA; McColl, DJ; Miller, MD; Wulfsohn, M | 1 |
Cauda, R; Cingolani, A; De Luca, A; Di Giambenedetto, S; Marzocchetti, A; Pompucci, A; Scoppettuolo, G; Tumbarello, M; Vago, G | 1 |
Abraira, V; Antela, A; Casado, JL; Dronda, F; Gutiérrez, C; López, D; Moreno, A; Moreno, S; Pérez-Elías, MJ; Rodríguez, MA | 1 |
Bower, M; Davies, E; Gazzard, B; Latham, V; Mandalia, S; Michailidis, C; Nelson, M; Stebbing, J | 1 |
Abraham, P; Malik, A; Malik, N | 1 |
de la Prada, FJ; Morey, A; Prados, AM; Saus, C; Tugores, A; Uriol, M | 1 |
Bainbridge, A; Jäger, HR; Miller, RF; Usiskin, SI | 1 |
Fernández Lisón, LC; Hevia Alonso, A; Pujol de la Llave, E; Rodríguez Gómez, FJ; Vázquez Domínguez, B | 1 |
Amoroso, A; Cleghorn, FR; Davis, CE; Gilliam, BL; Redfield, RR; Sajadi, MM | 1 |
Ahya, SN; Kanwar, YS; Palella, F; Patel, SM; Zembower, TR | 1 |
Arevalo, JF; Chavez de la Paz, E; de Clercq, E; Freeman, WR; Kirsch, LS; Munguia, D | 1 |
Folks, TM; Sandstrom, PA | 1 |
Arends, S; Kamp, W; Schokker, J; van Halteren, E | 1 |
Gazzard, BG; Morris-Jones, S; Nelson, M; Sadler, M | 1 |
Arevalo, JF; Banker, AS; Berry, C; De Clercq, E; Freeman, WR; Ishimoto, B; Munguia, D; Ochabski, R; Rahhal, FM; Taskintuna, I | 1 |
Boggs, J; Cheung, T; Corey, L; Drew, WL; Feinberg, J; Gathe, J; Jaffe, HS; Kessler, H; Kramer, F; Lalezari, J; Lee, S; McGuire, B; Safrin, S; Schacker, T | 1 |
Capparelli, EV; Cundy, KC; Freeman, WR; Rahhal, FM; Taskintuna, I | 1 |
Freeman, WR; Karavellas, MP; Macdonald, JC; Morse, LS; Reed, JB; Torriani, FJ | 1 |
Engler, RJ; Katial, RK; Myers, KW | 1 |
Anton, KE; Cherrington, JM; Hellmann, NS; Lamy, PD; Li, WX; Miller, MD; Mulato, AS | 1 |
Cinatl, J; Scholz, M; Vogel, JU | 1 |
Don, PC; Kaufmann, M; Lateef, F; Weinberg, JM; White, SM | 1 |
Baggett, TH; Gracia Jones, S | 1 |
Bowen, EF; Cherrington, JM; Emery, VC; Griffiths, PD; Johnson, MA; Lamy, PD | 1 |
Boucher, CA; Cambridge, E; De Groot, T; De Jong, S; Kamp, W; Schokker, J; Schuurman, R | 1 |
Warner, D | 1 |
Adams, DR; Butera, S; Folks, TM; Jackson, E; Jaffe, H; Janssen, R; Kim, CN; Otten, RA; Pullium, JK; Smith, DK | 1 |
Chou, S; Drew, WL; Miner, RC | 1 |
Norwood, CW; Oster, CN; Sparling, JD; Turiansky, GW | 1 |
Agbalika, F; Hocqueloux, L; Molina, JM; Oksenhendler, E | 1 |
Lagakos, SW; Weinberg, JM | 1 |
Torres, G | 1 |
Cordero, E; de Alarcón, A; Herrero-Romero, M; López-Cortés, LF; Pachón, J | 1 |
Bertelli, D; Bestetti, A; Cinque, P; Fausti, C; Lazzarin, A; Pierotti, C; Viganò, MG | 1 |
Alba, L; Ammassari, A; Antinori, A; Cauda, R; Cingolani, A; De Luca, A; Giancola, ML; Grisetti, S; Ippolito, G; Larussa, D; Monforte, A; Murri, R | 1 |
Delfraissy, JF; Gasnault, J; Kahraman, M; Kousignian, P; Matheron, S; Rahoiljaon, J; Taoufik, Y | 1 |
Clumeck, N; De Clercq, E; De Maubeuge, J; Snoeck, R; Van Laethem, Y | 1 |
Aksamit, AJ; Razonable, RR; Wilson, JW; Wright, AJ | 1 |
Chabrol, B; Chambost, H; Hugonenq, C; Lethel, V; Mancini, J; Michel, G | 1 |
Cohen, J | 1 |
Broder, S; Kageyama, S; Mitsuya, H; Yarchoan, R | 1 |
De Clercq, E | 2 |
Balzarini, J; Cozens, RM; De Clercq, E; Gangemi, JD; Hochkeppel, HK | 1 |
17 review(s) available for organophosphonates and Acquired Immune Deficiency Syndrome
Article | Year |
---|---|
[AIDS: ethics and scientific investigation on human beings].
Topics: Acquired Immunodeficiency Syndrome; Adenine; Animals; Anti-HIV Agents; Azathioprine; Clinical Trials as Topic; Congresses as Topic; Cyclosporine; Developing Countries; Ditiocarb; Double-Blind Method; Drug Evaluation, Preclinical; Drug Therapy, Combination; Ethics Committees, Research; Human Experimentation; Humans; Informed Consent; Mass Media; Oligodeoxyribonucleotides, Antisense; Organophosphonates; Practice Guidelines as Topic; Stavudine; Tenofovir; Thionucleotides | 2008 |
HIV prevention in southern Africa: why we must reassess our strategies?
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adolescent; Adult; Anti-HIV Agents; Circumcision, Male; Condoms; Condoms, Female; Female; HIV Infections; HIV Seropositivity; Humans; Interdisciplinary Communication; Male; Middle Aged; Organophosphonates; Preventive Medicine; Risk Reduction Behavior; Tenofovir; Young Adult | 2011 |
Relative risk of renal disease among people living with HIV: a systematic review and meta-analysis.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Anti-HIV Agents; Anti-Retroviral Agents; Chronic Disease; Female; HIV Infections; Humans; Kidney Diseases; Male; Odds Ratio; Organophosphonates; Survival Rate; Tenofovir | 2012 |
Osteoporosis and bone health in HIV.
Topics: Absorptiometry, Photon; Acquired Immunodeficiency Syndrome; Adenine; Alcohol Drinking; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Bone Density; Bone Density Conservation Agents; Female; Humans; Inflammation; Male; Organophosphonates; Osteomalacia; Osteoporosis; Osteoporotic Fractures; Smoking; Tenofovir; Weight Loss | 2012 |
The use of biomarkers for assessing HAART-associated renal toxicity in HIV-infected patients.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Antiretroviral Therapy, Highly Active; Biomarkers; Creatinine; Cystatin C; Fanconi Syndrome; Female; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Kidney Tubules, Proximal; Male; Organophosphonates; Retinol-Binding Proteins; Reverse Transcriptase Inhibitors; Tenofovir | 2012 |
Intracranial hypertension following highly active antiretroviral therapy interruption in an HIV-infected woman: case report and review of the literature.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Darunavir; Decompressive Craniectomy; Dideoxynucleosides; Female; Humans; Intracranial Hypertension; Lopinavir; Medication Adherence; Meningoencephalitis; Organophosphonates; Sulfonamides; Tenofovir; Treatment Outcome | 2013 |
Phosphonomethoxyalkyl analogs of nucleotides.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; DNA Virus Infections; Drug Design; Hepatitis B; Humans; Nucleotides; Organophosphonates; Structure-Activity Relationship | 2003 |
Treatment of chronic hepatitis B virus infection in patients co-infected with human immunodeficiency virus.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Antiretroviral Therapy, Highly Active; Antiviral Agents; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Organophosphorus Compounds; Prodrugs; Reverse Transcriptase Inhibitors; Tenofovir | 2003 |
Tenofovir-related nephrotoxicity: case report and review of the literature.
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adenine; Anti-HIV Agents; Clinical Chemistry Tests; Fanconi Syndrome; Female; Humans; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Inhibitors; Stavudine; Tenofovir; Time Factors; Treatment Outcome | 2004 |
Clinical and biologic aspects of human cytomegalovirus resistance to antiviral drugs.
Topics: Acquired Immunodeficiency Syndrome; Antiretroviral Therapy, Highly Active; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA Mutational Analysis; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Mutation; Organophosphonates; Phosphotransferases (Alcohol Group Acceptor); Viral Proteins; Virus Replication | 2004 |
Acute renal failure and Fanconi syndrome in an AIDS patient on tenofovir treatment--case report and review of literature.
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adenine; Anti-HIV Agents; Creatinine; Fanconi Syndrome; Female; Humans; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome | 2005 |
New strategies for treating AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Antiviral Agents; Capsid; Drug Design; Drug Resistance, Microbial; HIV-1; Humans; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Inhibitors; Tenofovir; Viral Core Proteins; Virus Replication; Zinc Fingers | 1996 |
Treatment of cytomegalovirus diseases.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds | 1997 |
Clinical update: new drugs for HIV/AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Alkynes; Anti-HIV Agents; Benzoxazines; Carbamates; Chemistry, Pharmaceutical; Cyclopropanes; Dideoxynucleosides; Drug Approval; Furans; HIV Protease Inhibitors; Humans; Organophosphonates; Oxazines; Reverse Transcriptase Inhibitors; Sulfonamides | 1999 |
Targeted therapy of human immunodeficiency virus-related disease.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Antiviral Agents; CD4 Antigens; Didanosine; Dideoxynucleosides; Dipyridamole; Drug Synergism; Gene Expression Regulation, Viral; Genes, nef; Genes, rev; Genes, tat; HIV; HIV Protease; Interferon Type I; Organophosphonates; RNA-Directed DNA Polymerase; Stavudine; Transcription, Genetic; Zalcitabine; Zidovudine | 1991 |
Chemotherapy of the acquired immune deficiency syndrome (AIDS): acyclic nucleoside phosphonate analogues.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Antiviral Agents; Cidofovir; Cytosine; DNA, Viral; Humans; Organophosphonates; Organophosphorus Compounds | 1991 |
New acquisitions in the development of anti-HIV agents.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Animals; Antiviral Agents; Dideoxynucleosides; Drug Design; HIV; Molecular Structure; Organophosphonates; Polysaccharides; Purines | 1989 |
22 trial(s) available for organophosphonates and Acquired Immune Deficiency Syndrome
Article | Year |
---|---|
Differential subcutaneous adipose tissue gene expression patterns in a randomized clinical trial of efavirenz or lopinavir-ritonavir in antiretroviral-naive patients.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adipogenesis; Adiponectin; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Body Composition; CCAAT-Enhancer-Binding Proteins; Cyclopropanes; Deoxycytidine; Drug Combinations; Emtricitabine; Energy Metabolism; Female; Gene Expression; Glucose; Glucose Transporter Type 4; HIV-1; Humans; Inflammation; Lipid Metabolism; Lipoprotein Lipase; Lopinavir; Male; Organophosphonates; Reverse Transcriptase Inhibitors; Ritonavir; Subcutaneous Fat; Tenofovir | 2014 |
Very high concentrations of active intracellular phosphorylated emtricitabine in neonates (ANRS 12109 trial, step 2).
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Antiviral Agents; Deoxycytidine; Emtricitabine; Female; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Maternal-Fetal Exchange; Organophosphonates; Phosphorylation; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Tenofovir | 2011 |
Plasma and intracellular tenofovir pharmacokinetics in the neonate (ANRS 12109 trial, step 2).
Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Female; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2011 |
Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Deoxycytidine; Double-Blind Method; Drug Administration Schedule; Emtricitabine; Female; HIV Reverse Transcriptase; HIV-1; Humans; Male; Middle Aged; Mutation; Nitriles; Nucleosides; Nucleotides; Organophosphonates; Pyrimidines; Reverse Transcriptase Inhibitors; Rilpivirine; Tenofovir; Treatment Outcome; Viral Load | 2011 |
Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Aged; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Deoxycytidine; Double-Blind Method; Drug Administration Schedule; Emtricitabine; Female; HIV Reverse Transcriptase; HIV-1; Humans; Male; Middle Aged; Mutation; Nitriles; Organophosphonates; Pyrimidines; Reverse Transcriptase Inhibitors; Rilpivirine; Tenofovir; Treatment Outcome; Viral Load | 2011 |
Effect of gender and race on the week 48 findings in treatment-naïve, HIV-1-infected patients enrolled in the randomized, phase III trials ECHO and THRIVE.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Black or African American; CD4 Lymphocyte Count; Cyclopropanes; Dideoxynucleosides; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Male; Nitriles; Organophosphonates; Pyrimidines; Rilpivirine; Sex Factors; Tenofovir; Treatment Outcome; Viral Load; Zidovudine | 2012 |
Supporting study product use and accuracy in self-report in the iPrEx study: next step counseling and neutral assessment.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Deoxycytidine; Directive Counseling; Double-Blind Method; Drug Therapy, Combination; Emtricitabine; Follow-Up Studies; Health Knowledge, Attitudes, Practice; Homosexuality, Male; Humans; Male; Medication Adherence; Organophosphonates; Patient Acceptance of Health Care; Self Report; Sexual Partners; Tenofovir; Transsexualism | 2012 |
Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Biomarkers; C-Reactive Protein; Cyclopropanes; Deoxycytidine; Dideoxynucleosides; Drug Combinations; Emtricitabine; Female; HIV-1; Humans; Inflammation; Interleukin-6; Lamivudine; Male; Oligopeptides; Organophosphonates; Pyridines; Ritonavir; Tenofovir; Tumor Necrosis Factor-alpha | 2012 |
Safety and efficacy of topical cidofovir to treat high-grade perianal and vulvar intraepithelial neoplasia in HIV-positive men and women.
Topics: Acquired Immunodeficiency Syndrome; Administration, Cutaneous; Adult; Aged; Antiviral Agents; Anus Neoplasms; Carcinoma in Situ; CD4 Lymphocyte Count; Cidofovir; Cyclin-Dependent Kinase Inhibitor p16; Cytosine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Proteins; Organophosphonates; Perineum; Prospective Studies; Vulvar Neoplasms | 2013 |
GlaxoSmithKline halts AIDS study.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Dideoxynucleosides; Drug Industry; Drug Therapy, Combination; Humans; Organophosphonates; Organophosphorus Compounds; Tenofovir; Treatment Failure | 2003 |
A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavir.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Alkynes; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; HIV-1; Humans; Indinavir; Male; Nelfinavir; Organophosphonates; Oxazines; Phenotype; Reverse Transcriptase Inhibitors; Treatment Failure | 2003 |
Genotypic and phenotypic predictors of the magnitude of response to tenofovir disoproxil fumarate treatment in antiretroviral-experienced patients.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Multivariate Analysis; Mutation; Organophosphonates; Organophosphorus Compounds; Phenotype; Placebos; Predictive Value of Tests; Regression Analysis; RNA, Viral; Tenofovir; Thymidine | 2004 |
Patterns of resistance emerging in HIV-1 from antiretroviral-experienced patients undergoing intensification therapy with tenofovir disoproxil fumarate.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Amino Acid Substitution; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; HIV Infections; HIV-1; Humans; Organophosphonates; Phenotype; Placebos; Polymorphism, Single Nucleotide; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; RNA, Viral; Tenofovir | 2004 |
High virological failure rate in HIV patients after switching to a regimen with two nucleoside reverse transcriptase inhibitors plus tenofovir.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Didanosine; Drug Resistance, Multiple, Viral; Female; Follow-Up Studies; HIV-1; Humans; Male; Middle Aged; Multivariate Analysis; Organophosphonates; Reverse Transcriptase Inhibitors; RNA, Viral; Tenofovir; Treatment Failure; Viral Load; Zidovudine | 2005 |
Intravitreal cidofovir (HPMPC) treatment of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Ciliary Body; Cytomegalovirus Retinitis; Cytosine; Drug Therapy, Combination; Female; Humans; Injections; Intraocular Pressure; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Probenecid; Retina; Uveitis; Vitreous Body | 1995 |
Safety of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) in patients with human immunodeficiency virus infection: a pilot study.
Topics: Acquired Immunodeficiency Syndrome; Adenine; AIDS-Related Complex; Alanine Transaminase; Aspartate Aminotransferases; CD4-Positive T-Lymphocytes; HIV Infections; Humans; Immunosuppressive Agents; Injections, Intravenous; Leukocyte Count; Organophosphonates | 1996 |
A randomized, double-blind, placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Animals; Antiviral Agents; Cells, Cultured; Chlorocebus aethiops; Cidofovir; Cytosine; Double-Blind Method; Drug Resistance, Microbial; Female; Foscarnet; Gels; Herpes Simplex; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mouth Mucosa; Organophosphonates; Organophosphorus Compounds; Simplexvirus; Vero Cells | 1997 |
Genotypic and phenotypic characterization of human immunodeficiency virus type 1 variants isolated from AIDS patients after prolonged adefovir dipivoxil therapy.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Drug Resistance, Microbial; Genotype; HIV Reverse Transcriptase; HIV-1; Humans; Mutation; Organophosphonates; Phenotype; Recombination, Genetic; Viral Load; Zidovudine | 1998 |
Effect of weekly adefovir (PMEA) infusions on HIV-1 virus load: results of a phase I/II study.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Antiviral Agents; CD4 Lymphocyte Count; HIV-1; Humans; Male; Middle Aged; Organophosphonates; RNA, Viral | 1999 |
Cidofovir added to highly active antiretroviral therapy in AIDS-associated progressive multifocal leukoencephalopathy.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cidofovir; Cytosine; Drug Therapy, Combination; Female; Humans; Leukoencephalopathy, Progressive Multifocal; Male; Organophosphonates; Organophosphorus Compounds | 2001 |
Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: extended follow-up of an observational study.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cidofovir; Cytosine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leukoencephalopathy, Progressive Multifocal; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Survival Rate | 2001 |
Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: a monocenter observational study with clinical and JC virus load monitoring.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cidofovir; Cytosine; Drug Therapy, Combination; Female; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Prospective Studies; Survival Analysis; Viral Load | 2001 |
68 other study(ies) available for organophosphonates and Acquired Immune Deficiency Syndrome
Article | Year |
---|---|
Refractory AIDS cholangiopathy: metabolic complications and the role of plasmapheresis.
Topics: Abdominal Pain; Acquired Immunodeficiency Syndrome; Adenine; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Cholangitis; Deoxycytidine; Emtricitabine; Humans; Jaundice; Male; Organophosphonates; Plasmapheresis; Pyrrolidinones; Raltegravir Potassium; Tenofovir; Treatment Outcome; Viral Load; Young Adult | 2013 |
FDA must publish data on safety and efficacy of prophylactic AIDS drug, court rules.
Topics: Access to Information; Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Deoxycytidine; Drug Combinations; Drug Therapy, Combination; Emtricitabine; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Humans; Organophosphonates; Organophosphorus Compounds; Publishing; Tenofovir; United States; United States Food and Drug Administration | 2013 |
Cobicistat + elvitegravir + emtricitabine + tenofovir. Two new drugs, but no progress.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Carbamates; Cobicistat; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; HIV-1; Humans; Organophosphonates; Quinolones; Tenofovir; Thiazoles | 2013 |
Direct and real-time quantification of tenofovir release from ph-sensitive microparticles into simulated biological fluids using (1)h nuclear magnetic resonance.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Delayed-Action Preparations; Female; Humans; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Male; Organophosphonates; Semen; Tenofovir; Vagina | 2014 |
CD4 count improvement following tenofovir to abacavir switch in a patient with persistent lymphopenia despite an undetectable viral load.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; CD4 Lymphocyte Count; Deoxycytidine; Dideoxynucleosides; Emtricitabine; Female; Humans; Lamivudine; Middle Aged; Organophosphonates; Tenofovir | 2008 |
Population pharmacokinetics of tenofovir in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Anti-HIV Agents; Drug Interactions; Female; Humans; Male; Middle Aged; Models, Biological; Organophosphonates; Prospective Studies; Tenofovir | 2008 |
[Complete HAART in a single pill. New milestone for improving compliance].
Topics: Acquired Immunodeficiency Syndrome; Adenine; Antiretroviral Therapy, Highly Active; Deoxycytidine; Drug Administration Schedule; Drug Combinations; Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV Infections; Humans; Organophosphonates; Oxazines; Viral Load | 2008 |
[Acute renal failure and hypercalcemia in an AIDS patient on tenofovir and low-dose vitamin D therapy with immune reconstitution inflammatory syndrome].
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adenine; Adrenal Cortex Hormones; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antitubercular Agents; Benzoxazines; Calcium; Cholecalciferol; Cyclopropanes; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Emtricitabine; Female; Humans; Hypercalcemia; Immune Reconstitution Inflammatory Syndrome; Kidney Function Tests; Mycobacterium avium-intracellulare Infection; Organophosphonates; Osteoporosis; Tenofovir | 2009 |
Trial results finally show potential for microbicidal HIV gel.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Female; Gels; HIV; HIV Infections; Humans; Organophosphonates; South Africa; Tenofovir; Vagina | 2010 |
Normal plasma FGF23 levels kinetic in tenofovir-related hypophosphatemic osteomalacia in an HIV-infected patient with von Recklinghausen disease.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Anti-HIV Agents; Drug Substitution; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hypophosphatemia; Male; Neurofibromatosis 1; Organophosphonates; Osteomalacia; Phosphates; Pyrrolidinones; Raltegravir Potassium; Tenofovir; Treatment Outcome | 2011 |
AIDS: Drugs that prevent HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Administration, Intravaginal; Administration, Oral; Animals; Anti-HIV Agents; Condoms; Controlled Clinical Trials as Topic; Deoxycytidine; Drug Combinations; Emtricitabine; Female; HIV Infections; Homosexuality, Male; Humans; Male; Medication Adherence; Organophosphonates; Placebos; Reverse Transcriptase Inhibitors; Safe Sex; Tenofovir; Vaginal Creams, Foams, and Jellies | 2011 |
Battles with donors cloud Malawi's HIV prevention plan.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Charities; Cyclopropanes; Drug Costs; Drug Therapy, Combination; Female; Health Policy; HIV Seropositivity; Humans; Infectious Disease Transmission, Vertical; International Cooperation; Lamivudine; Malawi; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2011 |
Evaluation of the safety and effectiveness of nevirapine plus coformulated tenofovir/emtricitabine as first-line therapy in routine clinical practice.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Deoxycytidine; Drug Combinations; Drug Therapy, Combination; Emtricitabine; Female; HIV Protease Inhibitors; Humans; Male; Middle Aged; Nevirapine; Organophosphonates; RNA, Viral; Spain; Tenofovir; Viral Load | 2012 |
Drug-induced uveitis in aids patients: two case reports.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Female; Humans; Organophosphonates; Rifabutin; Uveitis | 2011 |
Evaluation of functional respiratory parameters in AIDS patients assisted in the infectious diseases ambulatory care clinic of a tertiary care university hospital in Brazil.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Anti-HIV Agents; Brazil; Cross-Sectional Studies; Female; Hospitals, University; Humans; Male; Middle Aged; Muscle Strength; Organophosphonates; Outpatient Clinics, Hospital; Prospective Studies; Respiration; Respiratory Function Tests; Respiratory Muscles; Spirometry; Tenofovir | 2012 |
More trials are cut short, but not the debate over their trajectory.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Clinical Trials as Topic; Deoxycytidine; Emtricitabine; Heart Failure; Humans; Niacin; Organophosphonates; Tenofovir | 2012 |
Development of a combination microbicide gel formulation containing IQP-0528 and tenofovir for the prevention of HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Anti-Infective Agents; Cell Line; Chemistry, Pharmaceutical; Excipients; Gels; HIV-1; Humans; Organophosphonates; Pyrimidinones; Reverse Transcriptase Inhibitors; Solubility; Tenofovir; Viscosity | 2012 |
Discontinuation of Atripla as first-line therapy in HIV-1 infected individuals.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Anti-HIV Agents; California; Central Nervous System Diseases; Cohort Studies; Deoxycytidine; Depression; Dreams; Drug Combinations; Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; Humans; Male; New Jersey; Organophosphonates; Oxazines; Retrospective Studies; Reverse Transcriptase Inhibitors; Risk Factors; Sleep Initiation and Maintenance Disorders | 2012 |
Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Africa; Anti-HIV Agents; Deoxycytidine; Drug Administration Schedule; Drug Therapy, Combination; Emtricitabine; Female; Health Resources; Humans; India; Lopinavir; Male; Medication Adherence; Middle Aged; Mutation; Organophosphonates; Patient Selection; Pilot Projects; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Surveys and Questionnaires; Tenofovir; Thailand; Treatment Failure; Viral Load | 2012 |
Monitoring of HAART regime antiretrovirals in serum of acquired immunodeficiency syndrome patients by micellar liquid chromatography.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Chromatography, Liquid; Cyclopropanes; Drug Monitoring; Humans; Lamivudine; Organophosphonates; Stavudine; Tenofovir; Zidovudine | 2012 |
Antiviral therapy for cytomegalovirus infections in pediatric patients.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adolescent; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Child; Child, Preschool; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Infant; Injections, Intravenous; Organophosphonates; Organophosphorus Compounds; Time Factors | 2002 |
New antiretroviral agents.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Carbamates; Deoxycytidine; Dioxolanes; Drugs, Investigational; Emtricitabine; Furans; Guanosine; HIV Fusion Inhibitors; Humans; Imidazoles; Oligopeptides; Organophosphates; Organophosphonates; Organophosphorus Compounds; Prodrugs; Protease Inhibitors; Pyridines; Pyrones; Quinazolines; Reverse Transcriptase Inhibitors; Sulfonamides; Sulfur Compounds; Tenofovir | 2001 |
Anti-HIV agents. Tenofovir and Videx (ddi) EC--some caution required.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Didanosine; Humans; Organophosphonates; Organophosphorus Compounds; Tenofovir | 2002 |
Successful treatment of varicella zoster virus retinitis with aggressive intravitreal and systemic antiviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cidofovir; Cytosine; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Herpes Zoster Ophthalmicus; Humans; Injections, Intravenous; Male; Organophosphonates; Organophosphorus Compounds; Retinitis; Vitreous Body | 2002 |
Correlation between cidofovir-associated uveitis and failing immunorestoration during HAART.
Topics: Acquired Immunodeficiency Syndrome; Adult; Analysis of Variance; Antiretroviral Therapy, Highly Active; Case-Control Studies; Cidofovir; Cohort Studies; Confidence Intervals; Cytosine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Immunity; Immunocompromised Host; Infusions, Intravenous; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Probability; Recovery of Function; Reference Values; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Uveitis, Anterior | 2003 |
Acute renal failure associated with tenofovir treatment in a patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adenine; Anti-HIV Agents; HIV; Humans; Kidney Tubular Necrosis, Acute; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Tenofovir; Viral Load | 2003 |
Boom, or bust?
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Animals; Bacterial Vaccines; Biomedical Research; Bioterrorism; Cidofovir; Cytosine; Federal Government; Humans; Influenza Vaccines; Organophosphonates; Organophosphorus Compounds; Research Personnel; Research Support as Topic; Smallpox; United States | 2003 |
Tenofovir-related Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome: the role of lopinavir-ritonavir-didanosine.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Anti-HIV Agents; Diabetes Insipidus, Nephrogenic; Didanosine; Drug Therapy, Combination; Fanconi Syndrome; Humans; Lopinavir; Male; Organophosphonates; Organophosphorus Compounds; Pyrimidinones; Ritonavir; Tenofovir | 2003 |
[Viral hepatitis B/C and HIV. Therapy of double infections].
Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Antiviral Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Hepatitis B; Hepatitis C; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Treatment Outcome | 2003 |
[Resistance in a new light. About mutations and their interactions].
Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Drug Resistance, Multiple, Viral; HIV-1; Humans; Microbial Sensitivity Tests; Mutagenesis; Organophosphonates; Organophosphorus Compounds; Tenofovir; Treatment Outcome; Virus Replication | 2003 |
[First nucleotide analog with noteworthy safety profile. Tenofovir effective in all stages of the infection].
Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials, Phase III as Topic; Humans; Multicenter Studies as Topic; Organophosphonates; Organophosphorus Compounds; Randomized Controlled Trials as Topic; Tenofovir; Treatment Outcome; Virus Replication | 2003 |
[Infection due to acyclovir-resistant varicella-zoster herpes virus in a patient with AIDS].
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Viral; Fatal Outcome; Female; Foscarnet; Herpes Zoster; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Organophosphonates | 2004 |
Tenofovir-associated nephrotoxicity: Fanconi syndrome and renal failure.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Anti-HIV Agents; Fanconi Syndrome; Humans; Kidney Diseases; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Renal Insufficiency; Tenofovir | 2004 |
Progressive multifocal leukencephalopathy in patients on highly active antiretroviral therapy: survival and risk factors of death.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cidofovir; Cohort Studies; Cytosine; Female; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Male; Middle Aged; Organophosphonates; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Outcome | 2004 |
Fatal inflammatory AIDS-associated PML with high CD4 counts on HAART: a new clinical entity?
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; Brain; CD4 Lymphocyte Count; Cidofovir; Cytosine; Dideoxynucleosides; Encephalitis; False Negative Reactions; Fatal Outcome; Humans; Immunocompromised Host; Indinavir; JC Virus; Lamivudine; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Organophosphonates; Substance Abuse, Intravenous; Time Factors; Virus Activation; Zidovudine | 2004 |
Adherence to trizivir and tenofovir as a simplified salvage regimen is associated with suppression of viraemia and a decreased cholesterol.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cholesterol; Dideoxynucleosides; Drug Combinations; Erythrocyte Indices; Humans; Lamivudine; Organophosphonates; Patient Compliance; Salvage Therapy; Tenofovir; Viral Load; Viremia; Zidovudine | 2005 |
[Acute renal failure and proximal renal tubular dysfuntion in a patient with acquired immunodeficiency syndrome treated with tenofovir].
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adenine; Aged; Anti-HIV Agents; Fanconi Syndrome; Female; Humans; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir | 2006 |
Progressive multifocal leukoencephalopathy: serial high-b-value diffusion-weighted MR imaging and apparent diffusion coefficient measurements to assess response to highly active antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Brain; Diffusion; Diffusion Magnetic Resonance Imaging; HIV Protease Inhibitors; Humans; Leukoencephalopathy, Progressive Multifocal; Lopinavir; Male; Organophosphonates; Pyrimidinones; Ritonavir; Tenofovir; Zidovudine | 2007 |
[Use study of tenofovir DF in highly active anti-retroviral therapy].
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; Humans; Male; Middle Aged; Organophosphonates; Tenofovir | 2006 |
Tenofovir and abacavir combination therapy: lessons learned from an urban clinic population.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Aged; Anti-HIV Agents; Baltimore; Dideoxynucleosides; Drug Therapy, Combination; Female; Humans; Male; Medical Records; Middle Aged; Multicenter Studies as Topic; Organophosphonates; Retrospective Studies; Tenofovir; Treatment Failure; Urban Population; Viral Load | 2007 |
Early onset of tenofovir-induced renal failure: case report and review of the literature.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Antiretroviral Therapy, Highly Active; Biopsy; HIV Infections; Humans; Liver; Male; Organophosphonates; Renal Insufficiency; Tenofovir; Time Factors; Treatment Outcome | 2007 |
Test of new vaginal microbicide gel show promise for women.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Administration, Intravaginal; Anti-Infective Agents, Local; Anti-Retroviral Agents; Female; HIV; HIV Seronegativity; Humans; India; Organophosphonates; Safety; Tenofovir; Treatment Outcome; United States; Vaginal Creams, Foams, and Jellies | 2008 |
Successful treatment of cytomegalovirus encephalitis in an AIDS patient using cidofovir.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Cytosine; Encephalitis, Viral; Humans; Magnetic Resonance Imaging; Male; Organophosphonates; Organophosphorus Compounds; Treatment Outcome | 1997 |
Intraocular pressure and aqueous humor dynamics in patients with AIDS treated with intravitreal cidofovir (HPMPC) for cytomegalovirus retinitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anterior Chamber; Antiviral Agents; Aqueous Humor; Cidofovir; Ciliary Body; Cytomegalovirus Infections; Cytosine; Drug Administration Schedule; Female; Fluorophotometry; Humans; Injections; Intraocular Pressure; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Prospective Studies; Retinitis; Ultrasonography; Vitreous Body | 1997 |
Intravitreal and plasma cidofovir concentrations after intravitreal and intravenous administration in AIDS patients with cytomegalovirus retinitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cidofovir; Cohort Studies; Cytomegalovirus Infections; Cytosine; Humans; Injections; Injections, Intravenous; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Osmolar Concentration; Prospective Studies; Retinitis; Vitreous Body | 1998 |
Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Drug Therapy, Combination; Female; HIV Protease Inhibitors; HIV-1; Humans; Male; Organophosphonates; Organophosphorus Compounds; Recurrence; Virus Activation; Virus Replication | 1998 |
Probenecid hypersensitivity in AIDS: a case report.
Topics: Acquired Immunodeficiency Syndrome; Cidofovir; Cytosine; Drug Hypersensitivity; Herpes Simplex; Humans; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Probenecid; Uricosuric Agents | 1998 |
Treatment of acyclovir-resistant, foscarnet-unresponsive HSV infection with topical cidofovir in a child with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Anti-HIV Agents; Child, Preschool; Cidofovir; Cytosine; Drug Resistance, Microbial; Facial Dermatoses; Foscarnet; Herpes Simplex; Humans; Male; Organophosphonates; Organophosphorus Compounds; Treatment Failure | 1998 |
Quantitative changes in cytomegalovirus DNAemia and genetic analysis of the UL97 and UL54 genes in AIDS patients receiving cidofovir following ganciclovir therapy.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA-Directed DNA Polymerase; DNA, Viral; Ganciclovir; Genotype; Humans; Mutation; Organophosphonates; Organophosphorus Compounds; Phosphotransferases (Alcohol Group Acceptor); Prospective Studies; Retinitis; Viral Load; Viral Proteins | 1999 |
Incidental treatment of hepatitis B virus infection in an AIDS patient.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Anti-HIV Agents; Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Humans; Male; Organophosphonates; Reverse Transcriptase Inhibitors | 2000 |
Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2).
Topics: Acquired Immunodeficiency Syndrome; Adenine; Animals; Anti-HIV Agents; Female; HIV-2; Humans; Macaca nemestrina; Organophosphonates; Organophosphorus Compounds; RNA, Viral; Tenofovir; Vagina | 2000 |
A deletion mutation in region V of the cytomegalovirus DNA polymerase sequence confers multidrug resistance.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Drug Resistance, Multiple; Foscarnet; Ganciclovir; Gene Deletion; Humans; Mutation; Organophosphonates; Organophosphorus Compounds; Phosphotransferases; Transfection | 2000 |
Diagnostic and therapeutic dilemmas of a large scrotal lesion in an AIDS patient.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Biopsy; Cidofovir; Cytosine; Diagnosis, Differential; Fluorescent Antibody Technique, Direct; Herpes Genitalis; Herpesvirus 2, Human; Humans; Hyperplasia; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Scrotum; Skin; Skin Ulcer | 2001 |
Long-term remission of an AIDS-related primary effusion lymphoma with antiviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Burkitt Lymphoma; Cidofovir; Cytosine; Herpesvirus 4, Human; Herpesvirus 8, Human; HIV Long-Term Survivors; HIV Protease Inhibitors; Humans; Interferon-alpha; Lymphoma, B-Cell; Male; Organophosphonates; Organophosphorus Compounds; Pleural Effusion; Sarcoma, Kaposi; Time Factors | 2001 |
Efficiency comparisons of rank and permutation tests based on summary statistics computed from repeated measures data.
Topics: Acquired Immunodeficiency Syndrome; Adenine; HIV-1; Humans; Nevirapine; Organophosphonates; Protease Inhibitors; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Statistics as Topic; Viral Load | 2001 |
Black-bordered warning box for cidofovir.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cidofovir; Cytosine; Drug Labeling; Humans; Injections, Intravenous; Kidney; Organophosphonates; Organophosphorus Compounds | 1997 |
Second National Retrovirus conference: a further report.
Topics: Acetamides; Acetophenones; Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cause of Death; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Female; Ganciclovir; Humans; Male; Organophosphonates; Organophosphorus Compounds; Paclitaxel; Reverse Transcriptase Inhibitors; Sarcoma, Kaposi; Tuberculosis | 1995 |
Advances, challenges and growing frustration.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cachexia; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Costs; Drug Therapy, Combination; Growth Hormone; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Immunity, Cellular; Infectious Disease Transmission, Vertical; Organophosphonates; Organophosphorus Compounds; Politics; Reverse Transcriptase Inhibitors; Zidovudine | 1995 |
Acyclovir-resistant herpes: expanded access available for cidofovir gel (Forvade).
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Cidofovir; Cytosine; Drug Approval; Gels; Herpes Simplex; Humans; Organophosphonates; Organophosphorus Compounds | 1997 |
The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cidofovir; Cytosine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leukoencephalopathy, Progressive Multifocal; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Retrospective Studies; Survival Analysis | 2001 |
Treatment of a bowenoid papulosis of the penis with local applications of cidofovir in a patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Administration, Topical; Adult; Antiviral Agents; Bowen's Disease; Cidofovir; Cytosine; Homosexuality, Male; Humans; Male; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Penile Neoplasms; Skin Neoplasms; Tumor Virus Infections | 2001 |
Cidofovir treatment of progressive multifocal leukoencephalopathy in a patient receiving highly active antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cidofovir; Cytosine; Humans; Leukoencephalopathy, Progressive Multifocal; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Treatment Outcome | 2001 |
[Progressive multifocal leukoencephalopathy revealing AIDS in a 13-year-old girl].
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Age Factors; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cerebrospinal Fluid; Cidofovir; Cytosine; Female; HIV Seropositivity; Humans; Infectious Disease Transmission, Vertical; JC Virus; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Organophosphonates; Organophosphorus Compounds; Polymerase Chain Reaction; Prognosis; Time Factors | 2002 |
[No comparison with NRTI. Tenofovir is robust against resistance trouble].
Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Drug Resistance, Viral; HIV Infections; Humans; Organophosphonates; Organophosphorus Compounds; Tenofovir | 2002 |
[Nucleotide analog shows effectiveness in previously treated patients. The new kind of HAART].
Topics: Acquired Immunodeficiency Syndrome; Adenine; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Clinical Trials as Topic; HIV Infections; Humans; Organophosphonates; Organophosphorus Compounds; Tenofovir; Viral Load | 2002 |
[First nucleotide analog on the market. New drug for the pretreated patient].
Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Drug Approval; Drug Therapy, Combination; HIV Infections; Humans; Organophosphonates; Organophosphorus Compounds; Tenofovir | 2002 |
Vaccines. Monkey puzzles.
Topics: Acquired Immunodeficiency Syndrome; Adenine; AIDS Vaccines; Animals; Anti-HIV Agents; Clinical Trials as Topic; Haplorhini; HIV; Humans; Killer Cells, Natural; Macaca mulatta; Organophosphonates; Organophosphorus Compounds; SAIDS Vaccines; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Tenofovir; Viremia | 2002 |
9-(2-Phosphonylmethoxyethyl)adenine in the treatment of murine acquired immunodeficiency disease and opportunistic herpes simplex virus infections.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Animals; Antiviral Agents; Concanavalin A; Herpes Simplex; Interferons; Mice; Mice, Inbred C57BL; Mitogens; Opportunistic Infections; Organophosphonates; Spleen; Zidovudine | 1989 |